FeesSafety
Pluang+

PowerBank's 3.26 MW Camillus solar project on a closed landfill begins operation, boosting its renewable energy portfolio.

Market News
03 Nov 2026, 16:00 WIB
PRNewsWire
View Source
Bullish
PowerBank's 3.26 MW Camillus solar project on a closed landfill begins operation, boosting its renewable energy portfolio.

PowerBank Corporation announced that its 3.26 MW Camillus community solar project, built on a closed landfill in New York, has received permission to operate. This milestone highlights PowerBank's expertise in transforming challenging sites into productive renewable energy sources, adding to its track record of over 100 MW of completed projects and a development pipeline nearing 1 GW. The project enables local households to benefit from solar energy without installing panels, supporting PowerBank's growth in North America's expanding renewable energy market.

PowerBank's 3.26 MW solar project is valued at US$7.3 million, providing context for readers following renewable energy developments. For readers following the energy sector, here is Pluang's market snapshot as of Nov 03, 2026 20:21 WIB: Among 79 priced US energy stocks tradable on Pluang, 68 rose and 9 fell. Notable movers include SM Energy Company at USD 37.96 (+1.39%), Nextpower Inc. at USD 92.38 (+1.37%), and Vista Energy at USD 67.79 (+1.35%), with typical hold times ranging from 5 to 9 days and varied Pluang order activity.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
2 hours ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
2 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
2 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
3 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App